NEI Podcast

Latest Episodes:

E211 - (CME) More Than Memories: An Update on the Diagnosis and Treatment of Alzheimer's Disease Dec 27, 2023

Show notes

In this CME episode, Dr. Andrew Cutler interviews Dr. Dani Cabral about current and novel diagnostic tools and treatments for Alzheimer's disease.

Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://nei.global/e211-cme

Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.global/podcast

Interested in Psychopharmacology? Learn about the NEI Master Psychopharmacology Program: https://nei.global/mpp

Stay updated with email alerts and join our conversations on social. Follow us on:

YouTube: https://nei.global/youtube

Instagram: https://nei.global/instagram

LinkedIn: https://nei.global/linkedin

Facebook: https://nei.global/facebook

X: https://nei.global/twitter

E210 - The PsychopharmaStahlogy Show: Potential Therapeutic Indications for Psychedelics with Dr. Scott Aaronson Dec 20, 2023

Show notes

What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributable to psychological support? Is the psychedelic trip important for the therapeutic benefits of psychedelic treatments?

Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on the role of psychedelics in modern psychiatry.

Today, Dr. Andy Cutler interviews Dr. Scott Aaronson and Dr. Stephen Stahl about the potential indications and therapeutic benefits of psilocybin and other psychedelics.

Let's listen to Part 3 of our theme: Classic Psychedelics for the Modern Psychopharmacologist.

Subscribe to the NEI Podcast, so that you don't miss another episode!

E209 - (CME) Harnessing Pharmacogenomic Testing as a Tool in Major Depressive Disorder Treatment Dec 13, 2023

Show notes

In this CME episode, Dr. Andrew Cutler interviews Dr. Jeffrey Strawn about the role of pharmacogenomic testing in guiding treatment of major depressive disorder (MDD). They discuss how pharmacogenomic testing works, the impact of failed treatments and side effects on patients with MDD, and the clinical applications and future directions of pharmacogenomic testing.

Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://nei.global/e209-cme

Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.global/podcast

Interested in Psychopharmacology? Learn about the NEI Master Psychopharmacology Program: https://nei.global/mpp

Stay updated with email alerts and join our conversations on social. Follow us on:

YouTube: https://nei.global/youtube

Instagram: https://nei.global/instagram

LinkedIn: https://nei.global/linkedin

Facebook: https://nei.global/facebook

X: https://nei.global/twitter

E208 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre Dec 06, 2023

Show notes

What were some new treatments approved by the FDA? What did we learn about the long-term safety of methylphenidate in childhood ADHD? Are there benefits to long-term maintenance treatment with antidepressants in bipolar disorder? What did we learn about the safety and efficacy of subcutaneous racemic ketamine for treatment-resistant depression and MDMA for PTSD? In this episode, Dr. Andrew Cutler and Dr. Roger McIntyre address these questions and so much more about this past year in psychopharmacology.

Dr. Roger S. McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. Dr. McIntyre is involved in multiple research endeavors which primarily aim to characterize the association between mood disorders, notably cognitive function, and medical comorbidity. His work broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.

Resources:

This Month in Psychopharmacology

E207 - (CME) Don't Forget About Me: Addressing Residual Symptoms in Major Depressive Disorder Nov 29, 2023

Show notes

In this CME episode, Dr. Andrew Cutler interviews Dr. Vladimir Maletic about the impact of residual symptoms on patients with major depressive disorder, as well as treatment modifications to address residual symptoms in these individuals.

Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://nei.global/e207-cme

Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.global/podcast

Interested in Psychopharmacology? Learn about the NEI Master Psychopharmacology Program: https://nei.global/mpp

Stay updated with email alerts and join our conversations on social. Follow us on:

YouTube: https://nei.global/youtube

Instagram: https://nei.global/instagram

LinkedIn: https://nei.global/linkedin

Facebook: https://nei.global/facebook

X: https://nei.global/twitter

E206 - 2023 NEI Congress Extended Q&A: Anhedonia and Emotional Blunting with Dr. Vladimir Maletic Nov 17, 2023

Show notes

In this episode, Dr. Vladimir Maletic addresses your unanswered questions from his presentations, "From Despair to Delight: Advances in the Diagnosis and Treatment of Anhedonia" and "Ho Hum to Aha! Treating Anhedonia and Emotional Blunting."

E205 - 2023 NEI Congress Extended Q&A: Agitation in Dementia with Dr. Leslie Citrome Nov 17, 2023

Show notes

In this episode, Dr. Leslie Citrome addresses your unanswered questions from his presentation, There's No Place Like Home: Addressing Agitation in Dementia.

E204 - The PsychopharmaStahlogy Show: How Do Psychedelics Work Anyway? with Dr. Roger McIntyre Nov 16, 2023

Show notes

What is the role of the 5HT2A receptor in the therapeutic actions of psychedelics? What additional mechanisms may be involved in the therapeutic benefits of classic psychedelics? Is the psychedelic trip necessary for the therapeutic benefit of psychedelics?

Today, Dr. Andy Cutler interviews Dr. Roger McIntyre and Dr. Stephen Stahl about the current understanding of the neurobiological mechanisms underlying the therapeutic benefits of psychedelics.

Let's listen to Part 2 of our theme: Classic Psychedelics for the Modern Psychopharmacologist.

Subscribe to the NEI Podcast, so that you don't miss another episode!

E203 - 2023 NEI Congress Extended Q&A: Neurology for Psychiatrists with Dr. Laxman Bahroo Nov 11, 2023

Show notes

In this episode, Dr. Laxman Bahroo addresses your unanswered questions from his presentation, Neurology for Psychiatrists.

E202 - 2023 NEI Congress Extended Q&A: Therapeutic Potential of Psychedelics with Dr. Roger McIntyre Nov 11, 2023

Show notes

In this episode, Dr. Roger McIntyre addresses your unanswered questions from his presentation, Unveiling the Therapeutic Potential: Evidence Supporting the Use of Psychedelics for PTSD, SUD, and Other Indications, at the Pre-Conference Psychedelics Workshop.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected